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INTRODUCTION
Diabetes decreases the overall life expectancy and cause a
heavy burden on public health (1). Moreover, the Asia-pacific
region is considered to be on the verge of an emerging dia-
betes epidemic (2).
The development of type 2 diabetes is affected by genetic
and environmental determinants (3). Recently, one study inves-
tigated whether common variants of functional and position-
al candidate genes, including ADRB3,PPARG, ENPP1 and
CAPN10, were determinants of type 2 diabetes (4).
ENPP1, also called K121Q, has a glutamine substitution
for lysine at codon 121 (5). Type 2 diabetes is characterized
by insulin resistance (6), and ENPP1 plays an important role
in insulin resistance (7, 8). ENPP1 interacts with α -subunit
of the insulin receptor to interrupt signaling (9).
In previous studies, the K121Q polymorphism of the
human PC-1 gene was strongly associated with insulin resis-
tance (1, 3, 7, 10-12). However, there was no association
between insulin resistance and the K121Q variant (13, 14).
In addition, there were discrepancies for the impact of
ENPP1 polymorphism on obesity between ethnic groups
(5, 10, 13, 15-19).
Obesity increases the concentration of insulin in plasma
and is the major contributor of insulin resistance (20). Obe-
sity appears to be an effect modifier of type 2 diabetes in
D1057 carriers (21). The association of obesity with the genet-
ic variant of the insulin receptor substrate was identified in
other studies (21, 22). In the Chinese Han population, the
PC-1 Q121 allele was associated with insulin resistance. In
women, carriers of the Q allele had an increased risk for obe-
sity development (3). In Caucasians and African-Americans,
121Q carriers had an association with increased body mass
index (BMI) (23), and the three-allele risk type haploid QdelTG
with the Q allele increased the risk for obesity (24). Howev-
er, in the Danish population, there were no differences in
the distribution of frequencies of dominant types (KK wild
type and KQ/QQ variant type) and alleles (19).
The complexity of type 2 diabetes is related to factors such
as genetic heterogeneity, interactions between genes, and the
modulating role played by the environment (4).
In spite of these limitations, studies of type 2 diabetes and
genetic factors of obesity can predict the risks for develop-
ment of both type 2 diabetes and obesity in order to assist
primary prevention, and Korea is an appropriate country for
such studies because of the homogeneity of racial composi-
tion and lifestyle (25). 
Therefore, the aim of this study was to analyze the pres-
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The K121Q Polymorphism in ENPP1 (PC-1) Is Not Associated with
Type 2 Diabetes or Obesity in Korean Male Workers
Type 2 diabetes is characterized by insulin resistance, and ENPP1 plays an impor-
tant role in insulin resistance. We investigated the association of the ENPP1 K121Q
polymorphism with both diabetes and obesity (body mass index [BMI]) in Korean
male workers. The study design was case-control. Subjects were 1,945 male work-
ers (type 2 diabetes, 195; non-diabetes, 1,750) of nuclear power plants who received
examinations from March to October in 2004. We collected venous blood samples
under fasting (≥ ≥8 hr) conditions, calculated BMI by height and weight, and assessed
relevant biochemical factors. The results of this study demonstrated that the ENPP1
121Q genotype (KQ+QQ types) was not associated with type 2 diabetes (odds
ratios [OR], 0.854; 95% confidence interval [CI], 0.571-1.278) or obesity (OR, 0.933;
95% CI, 0.731-1.190). In addition, the frequency of the Q allele was not related to
type 2 diabetes (OR, 0.911; 95% CI, 0.630-1.319) or obesity (OR, 0.962; 95% CI,
0.767-1.205). We concluded that the ENPP1 121Q allele is not a critical determi-
nant for either diabetes or obesity in Korean males. The discordance between the
results of this study and those derived from studies of Dominican, South Asian, Cau-
casian, Finnish, and French populations might be due to differences in genetic
backgrounds between these populations. 
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Accepted : 17 November 2007ence of the ENPP1 polymorphism, not studied yet in Kore-
an population, to identify the association between genotypes
and allele with type 2 diabetes and obesity.
MATERIALS AND METHODS
Subjects
Subjects included 1,945 male workers working for Korea
Hydro & Nuclear Power company. This company is an elec-
tric power company located at Kori, Yonggwang, Ulchin,
Wolsung, and Seoul in Korea.
There were 195 male workers (age 48.2±6.7 yr, BMI
24.67±2.64 kg/m2) who were diagnosed as diabetics dur-
ing medical examinations conducted from March 2004 to
October. The 1,750 male workers (age 45.2±7.7 yr, BMI
24.77±2.64 kg/m2) in the control group were selected ran-
domly. We obtained information on the history of diabetes
through self-reported questionnaires.
Subjects were included if they met one of the criteria below
and their onset age was older than 20 yr old to exclude type
1 diabetes: 1) blood-sugar level before a meal exceeded 126
mg/dL twice or more; 2) blood-sugar level before a meal
exceeded 126 mg/dL once or more and blood-sugar level
two hours after a meal exceeded 200 mg/dL; 3) those who
reported that he had a history of diabetes in the question-
naire and being taken oral hypoglycemic agents.
The workers included in the obesity group were those
whose BMI was 25 kg/m2 or more.
After collecting a blood sample from vein in fasting (≥8
hr) status, we measured the blood-sugar level, insulin, and
lipid profile. We also measured height and weight to calcu-
late BMI. If fasting glucose levels were greater than 126 mg/
dL, we checked the 2 hr post-prandial plasma glucose level
at each site within 1 month. Height and weight were mea-
sured by autoanalyzer (Health Guard, Fanics, Seoul, Korea).
The fasting blood level was analyzed by glucose-oxidase assay
using an autochemistry analyzer. To determine the lipid pro-
file, total cholesterol was analyzed by enzyme assay using
cholesterol oxidase (COD), high density lipoprotein (HDL)
cholesterol by glycerol phosphate oxidase assay, low density
lipoprotein (LDL) cholesterol by direct surfactant assay. 
We carried out this study under the approval by the Eth-
nics Committee of the Asan Medical Center, and obtained
written consent from all subjects, providing subjects with
sufficient explanation to obtain informed consent.
DNA extraction and PCR
We extracted genomic DNA from buffy coats using the
GENErALLTM Blood SV kit (General Biosystem, Seoul,
Korea) and following the instructions suggested by the man-
ufacturer. The method of genotyping used to identify the
K121Q polymorphism in ENPP1 exon 4 was polymerase
chain reaction-restriction fragment length polymorphism
(PCR-RFLP), using DNA treated with a restriction enzyme
after PCR, based on the paper reported by Abate et al. (26). 
Statistical analysis
We carried out Student’s t-test to analyze the effects of
genotypes on biochemical parameters using genotypes as
factors. The Hardy-Weinberg equilibrium was computed
based on the  2 goodness-of-fit test. 
We also investigated the differences in frequencies of geno-
types between type 2 diabetic and normal groups, and between
obesity and normal groups by Fisher’s exact test. Associa-
tions were considered statistically significant at the p<0.05
level. The SPSS 12.0 (for window) statistical software pack-
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Type 2 diabetics
KK (n=164) KQ+QQ (n=31) p*
Non-diabetics
KK (n=1,433) KQ+QQ (n=317) p*
Age (yr) 48.3±6.5 47.4±7.7 0.48 45.1±7.7 45.6±7.5 0.32
BMI (kg/m
2) 24.6±2.7 24.8±2.5 0.75 24.1±2.7 23.9±2.8 0.23
SBP (mmHg) 130.4±14.0 132.0±18.6 0.64 127.2±15.4 127.0±15.3 0.86
DBP (mmHg) 84.1±10.3 85.1±12.0 0.63 81.4±10.8 81.2±10.6 0.78
FP glucose (mg/dL) 151.0±49.9 160.4±46.8 0.34 90.8±18.2 91.1±18.5 0.79
Total cholesterol (mg/dL) 211.3±40.4 211.5±42.3 0.98 201.6±38.3 200.6±38.2 0.67
HDL cholesterol (mg/dL) 48.4±12.7 45.5±14.6 0.25 50.8±13.2 50.7±13.7 0.96
LDL cholesterol (mg/dL) 130.7±34.2 132.0±37.9 0.85 126.3±31.3 123.3±32.2 0.12
Triglycerides (mg/dL) 187.6±155.4 182.5±108.3 0.86 141.7±86.7 141.3±114.7 0.94
CRP (mg/dL) 0.3±0.2 0.3±0.2 0.22 0.3±0.3 0.4±0.4 0.29
HOMA-IR 0.4±0.6 0.5±0.5 0.55 0.1±0.7 0.1±0.7 0.23
Table 1. Biochemical parameters of type 2 diabetic and non-diabetic subjects by genotypes of ENPP1 
*Unpaired two-tailed Student’s t-test.
The skewed HOMA-IR was transformed to natural logarithms to remove skewness. 
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FP, fasting glucose, CRP, C-reactive protein; HOMA-IR, Home-
ostasis Model Assessment: estimate of insulin resistance; HDL, high density lipoprotein; LDL, low density lipoprotein. age was used for statistical analysis.
RESULTS
The frequencies of the KK type, KQ type, and QQ type in
ENPP1 K121Q were 82.1%, 17% and 0.9%, respectively.
The homozygous type of Q carrier (QQ type) was added to
the heterozygous type (KQ type) because the frequency of
QQ type was very low (0.9%).
We investigated the differences in age, blood pressure, BMI,
and results of clinical examinations according to genotypes
of ENPP1 K121Q between the type 2 diabetic and non-
diabetic groups (Table 1).
When type 2 diabetics and non-diabetics were pooled (n=
1,945), there were no significant differences in BMI, sys-
tolic pressure, diastolic pressure, glucose value in fasting
status, total cholesterol, LDL cholesterol, HDL cholesterol,
triglyceride, C-reactive protein, and HOMA-IR between
the KK type and KQ+QQ type. In addition, there were no
significant differences in the same characteristics above bet-
ween type 2 diabetic group and non-diabetic groups (Table 1),
and between the obese group and non-obese groups (Table 2).
The frequencies of genotypes were in accordance with the
Hardy-Weinberg equilibrium (p=0.85). The odds ratio of
having a KQ+QQ genotype was 0.85 for diabetics versus
non-diabetics. The odds ratio of having a Q allele was 0.91
for diabetics versus non-diabetics. However, there was no
significant difference in the genotypic and allelic distribu-
tion between type 2 diabetics and non-diabetics (Table 3).
The odds of a KQ+QQ genotype were 0.93 for obese ver-
sus non-obese subjects. Furthermore, the odds of having a
Q allele were 0.96 for obese versus non-obese subjects. How-
ever, there was no significant difference in the genotypic and
allelic distribution between obese and non-obese (Table 4).
The frequency of the KK type in ENPP1 K121Q genotypes
was 82.1%, that of KQ+QQ type was 17.9% and that of
Q allele was 9.4%. There was no statistically significant dif-
ference in the distribution among these genotypes and alle-
les (p=0.81, p=0.89, respectively), although the 121Q carrier
and Q allele in obese and/or diabetics seemed to differ slight-
ly from those in the non-obese non-diabetics (reference group).
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Obese subjects
KK (n=576) KQ+QQ (n=120) p*
Non-obese subjects
KK (n=1,021) KQ+QQ (n=228) p*
Age (yr) 46.3±7.8 46.2±7.3 0.91 44.9±7.6 45.5±7.6 0.33
BMI (kg/m
2) 26.9±1.8 26.9±1.9 0.70 22.6±1.7 22.5±1.8 0.30
SBP (mmHg) 132.2±15.5 131.6±15.5 0.67 124.8±14.5 125.3±15.3 0.67
DBP (mmHg) 84.9±10.9 84.1±10.2 0.49 79.8±10.3 80.2±10.8 0.67
FP glucose (mg/dL) 101.6±32.5 104.8±35.9 0.34 94.3±27.8 93.3±25.3 0.59
Total cholesterol (mg/dL) 209.0±38.2 210.3±42.6 0.75 198.9±38.4 196.9±35.7 0.47
HDL cholesterol (mg/dL) 48.3±12.3 46.4±12.1 0.11 51.8±13.5 52.3±14.3 0.59
LDL cholesterol (mg/dL) 131.7±31.5 128.3±36.2 0.29 123.9±31.4 121.8±30.8 0.36
Triglycerides (mg/dL) 171.2±115.4 186.1±161.4 0.34 132.4±81.7 123.3±71.1 0.12
CRP (mg/dL) 0.3±0.2 0.4±0.5 0.08 0.4±0.3 0.3±0.2 0.54
HOMA-IR 0.4±0.6 0.4±0.7 0.81 -0.01±0.7 -0.1±0.6 0.17
Table 2. Biochemical parameters of obese and non-obese subjects according to genotypes of ENPP1 
*Unpaired two-tailed Student’s t-test.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FP, fasting glucose, CRP, C-reactive protein; HOMA-IR, Home-
ostasis Model Assessment: estimate of insulin resistance; HDL, high density lipoprotein; LDL, low density lipoprotein. 
*Fisher’s exact test.





Type 2 diabetics 164 31 195 356 34 390
(84.1) (15.9) (100.0) (91.3) (8.7) (100.0)
Non-diabetics 1,433 317 1,750 3,168 332 3,500
(81.9) (18.1) (100.0) (90.5) (9.5) (100.0)
Total 1,597 348 1,945 3,524 366 3,890
(82.1) (17.9) (100.0) (90.6) (9.4) (100.0)
OR* (95% CI) 0.85 (0.57-1.28) 0.91 (0.63-1.32)
Table 3. Frequencies of PC-1 K121Q genotypes according to
diabetes 
*Fisher’s exact test.





Obese 576 120 696 1,264 128 1,392
(82.8) (17.2) (100.0) (90.8) (9.2) (100.0)
Non-obese 1,021 228 1,249 2,260 238 2,498
(81.7) (18.3) (100.0) (90.5) (9.5) (100.0)
Total 1,597 348 1,945 3,524 366 3,890
(82.1) (17.9) (100.0) (90.6) (9.4) (100.0)
OR* (95% CI) 0.93 (0.73-1.19) 0.96 (0.77-1.21)
Table 4. Frequencies of PC-1 K121Q genotypes according to
obesity In determining the prevalence of the Q allele carriers (KQ
and QQ subjects) and Q allele, there were no significant
differences in the genotypic and allelic distribution with the
respect to any phenotypes (data not shown).
After adjusting for the effects of obesity, the probability
of type 2 diabetes in KQ+QQ type was 0.858 (data not
shown) and that in Q allele was 1.095, showing no signifi-
cant difference (Table 5). Moreover, after adjusting for the
effects of type 2 diabetes, the probability of developing obe-
sity in the KQ+QQ type was 0.936 (data not shown) and
that in the Q allele was 1.038, showing no significant dif-
ference (Table 6).
DISCUSSION
The results of studies of the association between ENPP1
K121Q variants and both type 2 diabetes and obesity in
several races are disparate. We carried out this study to inves-
tigate the association of K121Q variants with type 2 dia-
betes and obesity in Korean male workers.
Insulin resistance is a major component of the pathogene-
sis of type 2 diabetes (27), and insulin receptor kinase activ-
ity is impaired in muscle and other insulin-sensitive tissue
of many type 2 diabetic patients (28), and then a potential
inhibitor of the insulin receptor tyrosine kinase is identified
as the plasma-cell membrane differentiation antigen-1 (PC-
1) (29). Therefore, it is significant to analyze ENPP1 (PC-1)
polymorphism. 
In the previous studies of the association between type 2
diabetes and polymorphism in ENPP1, the K121Q mis-
sense mutation increased the odds ratio (OR) for type 2 dia-
betes in Dominican (10), South Asian, Caucasian (16), Finnish
(18), and French populations (24). Moreover, according to a
meta-analysis of the association between ENPP1 K121Q
variant and type 2 diabetes, the odds ratios were 1.30 (95%
confidence interval [CI], 1.13-1.50) (16) and 1.17 (95% CI,
1.10-1.25) (19), showing significant association. In this study,
121Q was not associated with type 2 diabetes, showing con-
sistent results with those in the Japanese population (5), Dan-
ish Caucasians (13), Oji-Cree population (17), Finnish popu-
lation (18), and Danish white subjects (19). Most type 2 dia-
betes in Koreans is characterized by non-obesity, thus the
ENPP1 K121Q mutant relevant to insulin resistance possi-
bly could be a candidate gene that is not appropriate to ex-
plain susceptibility to type 2 diabetes. This can be a possi-
ble explanation for the lack of association between ENPP1
121Q carrier and type 2 diabetes in this study.
Obesity is a main risk factor for the development of type
2 diabetes (20) and there is linear association between obesi-
ty and type 2 diabetes (3). In previous studies of the associa-
tion between obesity and polymorphism in ENPP1, 121Q
carriers and/or Q allele were associated with obesity in the
Chinese Han population (BMI of obesity group ≥27 kg/m2)
(3), Caucasians (BMI of obesity group >90th percentile),
African-American adults (BMI of obesity group >80th per-
centile) (23), French population (BMI of obesity group ≥95th
percentile) (24), and Dominican population (BMI of obesity
group ≥30 kg/m2) (10). However, in this study (BMI of
obesity group ≥25 kg/m2), there was no difference in dis-
tribution between obesity and 121Q carriers and presence
of the Q allele. This result was consistent with those from a
study of 7,333 Danes (19) and a Spanish population (14) in
which the BMI of the obesity group was 25 kg/m2 or high-
er. On the other hand, in Matsuoka’s study, K121 was asso-
ciated with an increased BMI (23). In this study, the percent-
age of subjects whose BMI was 30 kg/m2 or higher was too
low (2.5%) to investigate the effect of K121Q genotype on






Type 2  K 145  211 356 
diabetics (40.7) (59.3) (100.0)
Q1 5 1 9 3 4
(44.1) (55.9) (100.0)
Subtotal 160 230 390 
(41.0) (59.0) (100.0) 1.038
Non- K 1,119 2,049 3,168 (0.828-1.301)
diabetics (35.3) (64.7) (100.0)
Q 113 219 332
(34.0) (66.0) (100.0)
Subtotal 1,232 2,268 3,500
(35.2) (64.8) (100.0)












Obese K 145 1,119 1,264
(11.5) (88.5) (100.0)
Q 15 113 128
(11.7) (88.3) (100.0)
Subtotal 160 1,232 1,392
(11.5) (88.5) (100.0) 1.095 
Non-obese K 211 2,049 2,260 (0.756-1.585)
(9.3) (90.7) (100.0)
Q 19 219 238
(8.0) (92.0) (100.0)
Subtotal 230 2,268 2,498
(9.2) (90.8) (100.0)




OR, odds ratios; CI, confidence interval.obesity.
The results of the present study showed that the frequen-
cies of the Q allele was 8.7% in the type 2 diabetic group
and 9.2% in the obesity group, which was lower than those
in Finnish and Swedish populations (12.9-15.1%) (11), Dan-
ish Caucasians (14-16%) (13), South Asians in Chennai (14
%), Caucasians in Dallas (16%), South Asians in Dallas (19%)
(16), the Dominican population (54.2%) (10) and, Black chil-
dren (77%) (30). The frequencies of the Q allele investigat-
ed in this study might have a smaller statistical power to
explain any association with either type 2 diabetes or obesi-
ty with 121Q carriers (KQ+QQ) and/or the Q allele. 
In conclusion, the present study suggests that the ENPP1
K121Q polymorphism was not associated with type 2 dia-
betes and obesity. The results of negative associations in this
study might be attributable to the low prevalence of obesi-
ty, relatively younger age, and low frequencies of the 121Q
carriers. Large and prospective studies are needed to confirm
this preliminary observation in the Korean population.
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